• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts.

作者信息

Rome Benjamin N, Garrett Katherine R, Maini Luca

机构信息

Program on Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2025 Sep 2;8(9):e2530778. doi: 10.1001/jamanetworkopen.2025.30778.

DOI:10.1001/jamanetworkopen.2025.30778
PMID:40920386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12418123/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33eb/12418123/dbd19b824c19/jamanetwopen-e2530778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33eb/12418123/dbd19b824c19/jamanetwopen-e2530778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33eb/12418123/dbd19b824c19/jamanetwopen-e2530778-g001.jpg

相似文献

1
Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts.制造商折扣计划与覆盖缺口折扣下的医疗保险D部分节省情况
JAMA Netw Open. 2025 Sep 2;8(9):e2530778. doi: 10.1001/jamanetworkopen.2025.30778.
2
Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.预计降低丙型肝炎治疗药物的建议零售价后，制造商和医疗机构收入的变化。
JAMA Netw Open. 2019 Jul 3;2(7):e196541. doi: 10.1001/jamanetworkopen.2019.6541.
3
Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.2012 年至 2019 年期间，顶级胰岛素产品的毛额到净额泡沫中的商业和强制折扣评估。
JAMA Netw Open. 2023 Jun 1;6(6):e2318145. doi: 10.1001/jamanetworkopen.2023.18145.
4
Fiscal Impact of Expanded Medicare Coverage for GLP-1 Receptor Agonists to Treat Obesity.扩大医疗保险覆盖范围以使用GLP-1受体激动剂治疗肥胖症的财政影响。
JAMA Health Forum. 2025 Apr 4;6(4):e250905. doi: 10.1001/jamahealthforum.2025.0905.
5
Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.加利福尼亚州药房对医疗保险受益人的处方药折扣计划的遵守情况。
N Engl J Med. 2002 Mar 14;346(11):830-5. doi: 10.1056/NEJMsa122601.
6
Savings from drug discount cards: relief for Medicare beneficiaries?药品折扣卡带来的节省：给医疗保险受益人带来缓解了吗？
Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-198-209. doi: 10.1377/hlthaff.w4.198.
7
In-gap discounts in Medicare Part D and specialty drug use.医疗保险计划 D 中的缺口折扣与专科药物使用。
Am J Manag Care. 2017 Sep;23(9):553-559.
8
Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.医疗保险D部分计划中与品牌药处方相关的因素。
JAMA Netw Open. 2021 Mar 1;4(3):e210483. doi: 10.1001/jamanetworkopen.2021.0483.
9
A United States Cross-Sectional Analysis of Annual Out-of-Pocket Cost Disparities of Erectile Dysfunction Medications.美国勃起功能障碍药物年度自付费用差异的横断面分析。
Urol Pract. 2025 Sep;12(5):517-523. doi: 10.1097/UPJ.0000000000000823. Epub 2025 Apr 24.
10
Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.医疗保险处方药福利下建议的通用治疗替代方案的成本变异性。
J Manag Care Spec Pharm. 2014 Mar;20(3):283-90. doi: 10.18553/jmcp.2014.20.3.283.

本文引用的文献

1
Assessing the Effect of the Medicare Part D Redesign.评估医疗保险D部分重新设计的效果。
JAMA. 2025 Feb 25;333(8):663-664. doi: 10.1001/jama.2024.25827.